Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)

Smoking is regarded as a major risk factor for the development of cardiovascular diseases (CVD). This study investigates whether serelaxin (RLX, recombinant human relaxin‐2) endowed with promising therapeutic properties in CVD, can be credited of a protective effect against cigarette smoke (CS)‐indu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cell Mol Med
Auteurs principaux: Pini, Alessandro, Boccalini, Giulia, Baccari, Maria Caterina, Becatti, Matteo, Garella, Rachele, Fiorillo, Claudia, Calosi, Laura, Bani, Daniele, Nistri, Silvia
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4831370/
https://ncbi.nlm.nih.gov/pubmed/26915460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12802
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires